Semaglutide users who are eating less or experiencing GI fluid losses are at higher risk of suboptimal electrolyte status
Peptides in their lyophilised (freeze-dried) form are safe for transport as they are protected from UV light and remain stable in a freeze-dried state
Peptides expected to return to legal compounding status include: BPC-157 - studied for tissue repair, gut healing, and inflammation reduction Thymosin Alpha-1 - an immune-modulating peptide used in infectious disease and oncology support TB-500 (Thymosin Beta-4) - studied for muscle repair, flexibility, and recovery CJC-1295 and Ipamorelin - growth hormone-releasing peptides supporting sleep, metabolism, and lean muscle AOD-9604 - a peptide fragment studied for fat metabolism Selank and Semax - neuropeptides studied for cognitive function and anxiety GHK-Cu - a copper peptide studied for wound healing and regeneration MOTS-C - a mitochondrial peptide studied for metabolic regulation Important: Category 1 reclassification is not the same as FDA approval
10.1016/j.nbd.2016.07.007 Neurobiol
There is no approved injectable GHK-Cu product anywhere in the world
Publications reporting experimental, clinical, and ethnopharmacological evidence were also considered
